Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data

Imagem de Miniatura
Arquivos
art_ROMERO_Vaginal_progesterone_decreases_preterm_birth_and_neonatal_morbidity_2017.PDF (513.58 KB)
Citações na Scopus
169
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
ROMERO, R.
CONDE-AGUDELO, A.
EL-REFAIE, W.
RODE, L.
CETINGOZ, E.
SERRA, V.
ABDELHAFEZ, M. S.
TABOR, A.
Citação
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, v.49, n.3, p.303-314, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
ObjectiveTo assess the efficacy of vaginal progesterone for the prevention of preterm birth and neonatal morbidity and mortality in asymptomatic women with a twin gestation and a sonographic short cervix (cervical length 25 mm) in the mid-trimester. MethodsThis was an updated systematic review and meta-analysis of individual patient data (IPD) from randomized controlled trials comparing vaginal progesterone with placebo/no treatment in women with a twin gestation and a mid-trimester sonographic cervical length 25 mm. MEDLINE, EMBASE, POPLINE, CINAHL and LILACS (all from inception to 31 December 2016), the Cochrane Central Register of Controlled Trials, Research Registers of ongoing trials, Google Scholar, conference proceedings and reference lists of identified studies were searched. The primary outcome measure was preterm birth < 33 weeks' gestation. Two reviewers independently selected studies, assessed the risk of bias and extracted the data. Pooled relative risks (RRs) with 95% confidence intervals (CI) were calculated. ResultsIPD were available for 303 women (159 assigned to vaginal progesterone and 144 assigned to placebo/no treatment) and their 606 fetuses/infants from six randomized controlled trials. One study, which included women with a cervical length between 20 and 25 mm, provided 74% of the total sample size of the IPD meta-analysis. Vaginal progesterone, compared with placebo/no treatment, was associated with a statistically significant reduction in the risk of preterm birth < 33 weeks' gestation (31.4% vs 43.1%; RR, 0.69 (95% CI, 0.51-0.93); moderate-quality evidence). Moreover, vaginal progesterone administration was associated with a significant decrease in the risk of preterm birth < 35, < 34, < 32 and < 30 weeks' gestation (RRs ranging from 0.47 to 0.83), neonatal death (RR, 0.53 (95% CI, 0.35-0.81)), respiratory distress syndrome (RR, 0.70 (95% CI, 0.56-0.89)), composite neonatal morbidity and mortality (RR, 0.61 (95% CI, 0.34-0.98)), use of mechanical ventilation (RR, 0.54 (95% CI, 0.36-0.81)) and birth weight < 1500 g (RR, 0.53 (95% CI, 0.35-0.80)) (all moderate-quality evidence). There were no significant differences in neurodevelopmental outcomes at 4-5 years of age between the vaginal progesterone and placebo groups. ConclusionAdministration of vaginal progesterone to asymptomatic women with a twin gestation and a sonographic short cervix in the mid-trimester reduces the risk of preterm birth occurring at < 30 to < 35 gestational weeks, neonatal mortality and some measures of neonatal morbidity, without any demonstrable deleterious effects on childhood neurodevelopment. Published 2017. This article is a U.S. Government work and is in the public domain in the USA.
Palavras-chave
cervical length, prematurity, preterm delivery, progestins, progestogens, transvaginal ultrasound
URI
https://observatorio.fm.usp.br/handle/OPI/20101
Referências
  1. Aboulghar MM, 2012, REPROD BIOMED ONLINE, V25, P133, DOI 10.1016/j.rbmo.2012.03.013
  2. Altman DG, 1998, BRIT MED J, V317, P1309
  3. Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001
  4. Arabin B, 2006, ULTRASOUND OBST GYN, V27, P377, DOI 10.1002/uog.2694
  5. Barros-Silva J, 2014, J PERINAT MED, V42, P281, DOI 10.1515/jpm-2013-0115
  6. Blickstein I, 1997, J REPROD MED, V42, P680
  7. Blickstein I, 2004, CLIN PERINATOL, V31, P395, DOI 10.1016/j.clp.2004.04.002
  8. Brizot ML, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.02.021
  9. Burgess JL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.03.003
  10. Cetingoz E, 2011, ARCH GYNECOL OBSTET, V283, P423, DOI 10.1007/s00404-009-1351-2
  11. Chauhan SP, 2010, AM J OBSTET GYNECOL, V203, P305, DOI 10.1016/j.ajog.2010.04.031
  12. Conde-Agudelo A, 2000, OBSTET GYNECOL, V95, P899, DOI 10.1016/S0029-7844(99)00640-7
  13. Conde-Agudelo A, 2016, AM J OBSTET GYNECOL, V214, P235, DOI 10.1016/j.ajog.2015.09.102
  14. Conde-Agudelo A, 2015, AM J OBSTET GYNECOL, V213, P789, DOI 10.1016/j.ajog.2015.06.015
  15. Conde-Agudelo A, 2014, AM J OBSTET GYNECOL, V211, P583, DOI 10.1016/j.ajog.2014.07.047
  16. Conde-Agudelo A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.064
  17. Crane JMG, 2008, ULTRASOUND OBST GYN, V31, P579, DOI 10.1002/uog.5323
  18. Crowther CA, 2010, COCHRANE DB SYST REV, V7
  19. Deeks JJK, 2011, COCHRANE HDB SYSTEMA
  20. Domin CM, 2010, ULTRASOUND Q, V26, P241, DOI 10.1097/RUQ.0b013e3181fe0e05
  21. El-refaie W, 2016, ARCH GYNECOL OBSTET, V293, P61, DOI 10.1007/s00404-015-3767-1
  22. Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815
  23. Gates S, 2004, BJOG-INT J OBSTET GY, V111, P213, DOI 10.1111/j.1471-0528.2004.00059.x
  24. Gibson JL, 2004, ULTRASOUND OBST GYN, V23, P561, DOI 10.1002/uog.1048
  25. Goldenberg RL, 1996, AM J OBSTET GYNECOL, V175, P1047, DOI 10.1016/S0002-9378(96)80051-2
  26. Goodnight W, 2009, OBSTET GYNECOL, V114, P1121, DOI 10.1097/AOG.0b013e3181bb14c8
  27. GRADEpro GDT, 2015, GRADEPRO GUID DEV TO
  28. Hamilton BE, 2015, NATL VITAL STAT REP, V64, P1
  29. Hassan SS, 2000, AM J OBSTET GYNECOL, V182, P1458, DOI 10.1067/mob.2000.106851
  30. Henderson J, 2004, ARCH DIS CHILD, V89, pF542, DOI 10.1136/adc.2003.043851
  31. Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
  32. Higgins JP, 2011, COCHRANE COLLABORATI, DOI 10.1136/BMJ.D5928
  33. Honest H, 2003, ULTRASOUND OBST GYN, V22, P305, DOI 10.1002/uog.202
  34. Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430
  35. Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904
  36. Kindinger LM, 2016, BJOG-INT J OBSTET GY, V123, P877, DOI 10.1111/1471-0528.13575
  37. Kindinger L, 2014, REPROD SCI, V21, p256A
  38. Kinzler WL, 2000, J SOC GYNECOL INVEST, V7, P321, DOI 10.1016/S1071-5576(00)00084-8
  39. Klebanoff MA, 2007, AM J OBSTET GYNECOL, V197, p10A, DOI 10.1016/j.ajog.2007.02.030
  40. Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1016/j.jclinepi.2009.06.006]
  41. Liem S, 2013, LANCET, V382, P1341, DOI 10.1016/S0140-6736(13)61408-7
  42. Lim AC, 2011, ULTRASOUND OBST GYN, V38, P10, DOI 10.1002/uog.9013
  43. Lorenz JM, 2012, SEMIN PERINATOL, V36, P201, DOI 10.1053/j.semperi.2012.02.005
  44. Luke B, 2005, AM J OBSTET GYNECOL, V192, P909, DOI 10.1016/j.ajog.2004.05.057
  45. Martin JA, 2012, NCHS DATA BRIEF, V80, P1
  46. McNamara HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122341
  47. Melamed N, 2016, AM J OBSTET GYNECOL, V215
  48. Melamed N, 2016, AM J OBSTET GYNECOL, V215
  49. Nicolaides KH, 2016, AM J OBSTET GYNECOL, V214, P3
  50. Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8
  51. Pagani G, 2016, ULTRASOUND OBST GYN, V48, P56, DOI 10.1002/uog.15668
  52. Pharoah POD, 2006, CLIN PERINATOL, V33, P301, DOI 10.1016/j.clp.2006.03.017
  53. Rafael TJ, 2014, COCHRANE DB SYST REV, V9
  54. Rode L, 2011, ULTRASOUND OBST GYN, V38, P272, DOI 10.1002/uog.9093
  55. Romero R, 2016, ULTRASOUND OBST GYN, V48, P308, DOI 10.1002/uog.15953
  56. Romero R, 2013, J PERINAT MED, V41, P27, DOI 10.1515/jpm-2012-0272
  57. Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003
  58. Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5
  59. Schuit E, 2015, BJOG-INT J OBSTET GY, V122, P27, DOI 10.1111/1471-0528.13032
  60. Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010
  61. Schunemann H., 2013, GRADE HDB GRADING QU
  62. Serra V, 2013, BJOG-INT J OBSTET GY, V120, P50, DOI 10.1111/j.1471-0528.2012.03448.x
  63. Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa
  64. Sperling L, 2005, ULTRASOUND OBST GYN, V26, P138, DOI 10.1002/uog.1938
  65. To MS, 2006, AM J OBSTET GYNECOL, V194, P1360, DOI 10.1016/j.ajog.2005.11.001
  66. Vedel C, 2016, ULTRASOUND OBST GYN, V48, P382, DOI 10.1002/uog.15948
  67. Vogel JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070549
  68. Walker MC, 2004, BJOG-INT J OBSTET GY, V111, P1294, DOI 10.1111/j.1471-0528.2004.00345.x
  69. Wood S, 2012, J PERINAT MED, V40, P593, DOI 10.1515/jpm-2012-0057
  70. Yamasmit W, 2015, COCHRANE DB SYST REV, V12
  71. Yelland LN, 2011, PAEDIATR PERINAT EP, V25, P283, DOI 10.1111/j.1365-3016.2011.01196.x

Coleções
Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/57
Artigos e Materiais de Revistas Científicas - ODS/03